Eyebright Medical Technology (Beijing) Co., Ltd. Stock
Equities
688050
CNE1000041J5
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
141.6 CNY | -0.94% | -8.06% | -17.69% |
Sales 2024 * | 1.38B 191M | Sales 2025 * | 1.88B 260M | Capitalization | 14.9B 2.06B |
---|---|---|---|---|---|
Net income 2024 * | 394M 54.39M | Net income 2025 * | 532M 73.44M | EV / Sales 2024 * | 10.6 x |
Net cash position 2024 * | 215M 29.62M | Net cash position 2025 * | 393M 54.25M | EV / Sales 2025 * | 7.71 x |
P/E ratio 2024 * |
38.3
x | P/E ratio 2025 * |
27.7
x | Employees | 2,074 |
Yield 2024 * |
0.43% | Yield 2025 * |
0.59% | Free-Float | 61.52% |
1 day | -0.94% | ||
1 week | -8.06% | ||
Current month | -4.81% | ||
1 month | +0.07% | ||
3 months | -12.75% | ||
6 months | -24.40% | ||
Current year | -17.69% |
Managers | Title | Age | Since |
---|---|---|---|
Jiang Bing Xie
CEO | Chief Executive Officer | 52 | 10-04-20 |
Zhao Wang
FOU | Founder | 43 | 11-07-31 |
Dan Xuan Wang
CHM | Chairman | 42 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Feng Jiang
BRD | Director/Board Member | 61 | 22-01-24 |
Jiang Bing Xie
CEO | Chief Executive Officer | 52 | 10-04-20 |
Shao Hua Wang
BRD | Director/Board Member | 54 | 10-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 141.6 | -0.94% | 467,616 |
24-05-27 | 143 | +1.17% | 542,020 |
24-05-24 | 141.3 | -2.86% | 833,172 |
24-05-23 | 145.4 | -2.19% | 540,199 |
24-05-22 | 148.7 | -0.77% | 504,367 |
End-of-day quote Shanghai S.E., May 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.69% | 2.08B | |
+5.07% | 19B | |
+7.14% | 14.17B | |
+10.34% | 10.61B | |
+3.10% | 1.74B | |
+15.03% | 1.43B | |
+10.00% | 594M | |
0.00% | 428M | |
+76.68% | 216M | |
+20.04% | 95.21M |
- Stock Market
- Equities
- 688050 Stock